Who
William J. Plovanic
Director
Company insider
Files Form 4 as: Director, TELA Bio; President & CEO, Vyome Holdings.
In numbers
- Trades disclosed
- 26
- Buys
- 4
- Sells
- 0
- Bought
- $279K
- Sold
- $0
- Companies
- 2
- Companies where not an officer
- 1
- First trade
- 9 Nov 2016
- Last trade
- 15 Oct 2026
- Last filed
- 19 Oct 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 15 Oct 2026filed 19 Oct 2026 | TELA TELA BioMedical Devices | SEC FORM 4 Code A | $16K16,089 at $1.01 | filing |
| 15 Jul 2026filed 17 Jul 2026 | TELA TELA BioMedical Devices | SEC FORM 4 Code A | $16K20,930 at $0.785 | filing |
| 15 Jul 2026filed 17 Jul 2026 | TELA TELA BioMedical Devices | SEC FORM 4 Code A | $17K20,930 at $0.79 | filing |
| 9 Jun 2026filed 11 Jun 2026 | TELA TELA BioMedical Devices | SEC FORM 4 Code A | —11,675 at $0.00 | filing |
| 9 Jun 2026filed 11 Jun 2026 | TELA TELA Biooption or derivative · Medical Devices | SEC FORM 4 Code A | —17,335 at $0.00 | filing |
| 9 Jun 2026filed 11 Jun 2026 | TELA TELA Biooption or derivative · Medical Devices | SEC FORM 4 Code A | —17,335 at $0.00 | filing |
| 9 Jun 2026filed 11 Jun 2026 | TELA TELA BioMedical Devices | SEC FORM 4 Code A | —11,675 at $0.00 | filing |
| 31 Oct 2025filed 3 Nov 2025 | TELA TELA Biooption or derivative · Medical Devices | SEC FORM 4 Code A | —17,550 at $0.00 | filing |
| 31 Oct 2025filed 3 Nov 2025 | TELA TELA BioMedical Devices | SEC FORM 4 Code A | —11,925 at $0.00 | filing |
| 16 Sep 2020filed 18 Sep 2020 | HIND Vyome Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code A | —27,250 at $0.00 | filing |
| 16 Sep 2020filed 18 Sep 2020 | HIND Vyome Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code A | —27,250 at $0.00 | filing |
| 24 Jan 2020filed 28 Jan 2020 | HIND Vyome Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code A | —441,125 at $0.00 | filing |
| 12 Nov 2019filed 14 Nov 2019 | HIND Vyome HoldingsBiotechnology | SEC FORM 4 Bought | $108K65,000 at $1.66 | filing |
| 25 Oct 2019filed 28 Oct 2019 | HIND Vyome Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code A | —10,000 at $0.00 | filing |
| 6 Aug 2019filed 8 Aug 2019 | HIND Vyome Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code P | —9,375 at $0.00 | filing |
| 6 Aug 2019filed 8 Aug 2019 | HIND Vyome HoldingsBiotechnology | SEC FORM 4 Bought | $50K12,500 at $4.00 | filing |
| 23 Jul 2019filed 25 Jul 2019 | HIND Vyome Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code A | —300,000 at $0.00 | filing |
| 2 Jan 2019filed 4 Jan 2019 | HIND Vyome Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code A | —100,000 at $0.00 | filing |
| 23 Aug 2018filed 27 Aug 2018 | HIND Vyome HoldingsBiotechnology | SEC FORM 4 Code A | $50K27,472 at $1.82 | filing |
| 15 May 2018filed 17 May 2018 | HIND Vyome HoldingsBiotechnology | SEC FORM 4 Code A | —45,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.